[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immutep Ltd ADR (IMMP)

Immutep Ltd ADR (IMMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,572
  • Shares Outstanding, K 147,372
  • Annual Sales, $ 6,690 K
  • Annual Income, $ -39,780 K
  • EBIT $ 0 M
  • EBITDA $ -37 M
  • 60-Month Beta 2.21
  • Price/Sales 8.01
  • Price/Cash Flow N/A
  • Price/Book 0.83
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/29/25
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 403.79% (+27.45%)
  • Historical Volatility 71.13%
  • IV Percentile 83%
  • IV Rank 28.64%
  • IV High 1,253.85% on 02/12/26
  • IV Low 62.69% on 10/03/25
  • Expected Move (DTE 2) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 151
  • Volume Avg (30-Day) 168
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 6,204
  • Open Int (30-Day) 4,484
  • Expected Range 0.3562 to 0.3562

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3465 +2.80%
on 06/11/26
0.5394 -33.96%
on 05/19/26
-0.1635 (-31.46%)
since 05/15/26
3-Month
0.2928 +21.65%
on 04/13/26
1.0499 -66.07%
on 04/15/26
-0.1091 (-23.45%)
since 03/16/26
52-Week
0.2928 +21.65%
on 04/13/26
3.5299 -89.91%
on 12/08/25
-1.3538 (-79.17%)
since 06/16/25

Most Recent Stories

More News
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 15, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited ("Immutep"...

IMMP : 0.3562 (-3.81%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP

NEW YORK , June 11, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP). Such investors are...

IMMP : 0.3562 (-3.81%)
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

LOS ANGELES , June 11, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP ) for violations...

IMMP : 0.3562 (-3.81%)
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 11, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited ("Immutep"...

IMMP : 0.3562 (-3.81%)
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026

Alert: Immutep's 83% Single-Day ADR Collapse Quantifies the Market's Violent Repricing of TACTI-004 Risk That Was Allegedly Known Internally

IMMP : 0.3562 (-3.81%)
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 8, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited ("Immutep"...

IMMP : 0.3562 (-3.81%)
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

LOS ANGELES , June 8, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP ) for violations...

IMMP : 0.3562 (-3.81%)
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit

NEW YORK , June 5, 2026 /PRNewswire/ --

IMMP : 0.3562 (-3.81%)
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

LOS ANGELES , June 5, 2026 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP ) for violations...

IMMP : 0.3562 (-3.81%)
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 5, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited ("Immutep"...

IMMP : 0.3562 (-3.81%)

Business Summary

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the...

See More

Key Turning Points

3rd Resistance Point 0.3774
2nd Resistance Point 0.3731
1st Resistance Point 0.3646
Last Price 0.3562
1st Support Level 0.3518
2nd Support Level 0.3475
3rd Support Level 0.3390

See More

52-Week High 3.5299
Fibonacci 61.8% 2.2933
Fibonacci 50% 1.9114
Fibonacci 38.2% 1.5294
Last Price 0.3562
52-Week Low 0.2928

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.